Merck KGaA has faced a challenge in the clinical evaluation of its investigation...
The phase 1 T-cell engager developed by Amgen and CytomX Therapeutics was termin...
The FDA has granted orphan drug designation to Plus Therapeutics’ injectable rad...
NICE previously rejected Leqembi and Kisunla for NHS coverage in August and Octo...
J&J's news about aticaprant's Phase III programme comes two months after Neumora...
The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indi...
Closing the gap in health interventions between men and women could add $1tn to ...
A recent publication in the esteemed journal Engineering has sparked conversatio...
In a groundbreaking development for the dairy industry, researchers have made si...
Eradivir, a clinical-stage biotech firm specializing in small molecule immunothe...
In a groundbreaking study published in the journal Engineering, researchers are ...
In the world of biomaterials, few substances have generated as much interest and...
A recent groundbreaking study in the journal Engineering has unveiled a revoluti...
In recent years, the understanding of cancer biology has significantly advanced,...
In the realm of medical advancements, the recognition of genetic factors in canc...
In an exciting advancement in plant biology, researchers at Washington Universit...
